KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Times Interest Earned: 2011-2023

Historic Times Interest Earned for Supernus Pharmaceuticals (SUPN) over the last 12 years, with Jun 2023 value amounting to -$19.33.

  • Supernus Pharmaceuticals' Times Interest Earned fell 408.31% to -$19.33 in Q2 2023 from the same period last year, while for Jun 2023 it was $3.56, marking a year-over-year increase of 6.79%. This contributed to the annual value of -$2.18 for FY2023, which is 133.44% down from last year.
  • Supernus Pharmaceuticals' Times Interest Earned amounted to -$19.33 in Q2 2023, which was down 661.94% from $3.44 recorded in Q1 2023.
  • Supernus Pharmaceuticals' Times Interest Earned's 5-year high stood at $21.54 during Q4 2022, with a 5-year trough of -$19.33 in Q2 2023.
  • Over the past 3 years, Supernus Pharmaceuticals' median Times Interest Earned value was $2.80 (recorded in 2023), while the average stood at $2.70.
  • In the last 5 years, Supernus Pharmaceuticals' Times Interest Earned spiked by 1,996.02% in 2022 and then slumped by 408.31% in 2023.
  • Quarterly analysis of 5 years shows Supernus Pharmaceuticals' Times Interest Earned stood at $7.07 in 2019, then decreased by 0.17% to $7.05 in 2020, then crashed by 85.43% to $1.03 in 2021, then skyrocketed by 1,996.02% to $21.54 in 2022, then slumped by 408.31% to -$19.33 in 2023.
  • Its Times Interest Earned stands at -$19.33 for Q2 2023, versus $3.44 for Q1 2023 and $21.54 for Q4 2022.